Mediclinic International PLC 2.2% potential upside indicated by Barclays

Mediclinic International PLC with ticker (LON:MDC) now has a potential upside of 2.2% according to Barclays.



Barclays set a target price of 504 GBX for the company, which when compared to the Mediclinic International PLC share price of 493 GBX at opening today (04/10/2022) indicates a potential upside of 2.2%. Trading has ranged between 286 (52 week low) and 504 (52 week high) with an average of 3,472,715 shares exchanging hands daily. The market capitalisation at the time of writing is £3,637,560,864.

M.D.C. Holdings, Inc. is engaged in the business of homebuilding and financial services. The Company’s segments include West, including segments located in Arizona, California, Nevada and Washington, and Oregon; Mountain, including segments located in Colorado and Utah; East, including segments located in the mid-Atlantic, which includes Virginia and Maryland, and Florida; mortgage operations, including HomeAmerican Mortgage Corporation, and Other, which includes Allegiant Insurance Company, Inc., StarAmerican Insurance Ltd., American Home Insurance Agency, Inc. and American Home Title and Escrow Company. The homebuilding operations consist of subsidiary companies that purchases finished lots or develop lots necessary for the construction and sale of single-family detached homes to first-time and first-time move-up homebuyers under the name Richmond American Homes. It also includes land acquisition and development, home construction, and sales and marketing, and customer service.